oligometastatic cancer
Showing 1 - 25 of >10,000
Driven by Disease Biology et/or Immunoactivity (PROMETEO)
Recruiting
- Oligometastatic Prostate Cancer
-
Aviano, Pordenone, Italy
- +1 more
Sep 25, 2023
Metastatic Prostate Cancer Trial in Toronto (Enzalutamide, Standard of Care SBRT and ADT)
Not yet recruiting
- Metastatic Prostate Cancer
- Enzalutamide
- Standard of Care SBRT and ADT
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Center
Oct 6, 2022
Metastasis, Metastatic Breast Cancer, Metastatic Prostate Cancer Trial in Spain (To propose a diagnostic test to determine the
Recruiting
- Metastasis
- +4 more
- To propose a diagnostic test to determine the viability of Stereotactic ABlative Radiotherapy (SABR).
- +2 more
-
Reus, Tarragona, Spain
- +20 more
Jul 3, 2023
Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Cairo (radiation, procedure, other)
Recruiting
- Breast Cancer
- +2 more
- Stereotactic Ablative Radiation Therapy
- +2 more
-
Cairo, EgyptNational Cancer Institute
Nov 20, 2023
Esophageal Squamous Cell Carcinoma, Oligometastatic Disease Trial in Beijing (Esophagectomy)
Active, not recruiting
- Esophageal Squamous Cell Carcinoma
- Oligometastatic Disease
- Esophagectomy
-
Beijing, China
- +1 more
Jul 11, 2023
Oligometastatic Renal Cell Carcinoma Trial in Houston (Pembrolizumab, Radiation therapy)
Not yet recruiting
- Oligometastatic Renal Cell Carcinoma
- Pembrolizumab
- Radiation therapy
-
Houston, TexasM D Anderson Cancer Center
Aug 21, 2023
Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)
Not yet recruiting
- Oligometastatic Prostate Cancer
- Quemliclustat
- +3 more
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Jun 14, 2023
Oligometastatic Squamous Cell Carcinoma of the Head and Neck Trial (Pembrolizumab, stereotattic ablation radiotherapy (SABR))
Not yet recruiting
- Oligometastatic Squamous Cell Carcinoma of the Head and Neck
- Pembrolizumab
- stereotattic ablation radiotherapy (SABR)
- (no location specified)
Apr 14, 2023
Unresectable Hepatocellular Carcinoma, Oligometastatic Disease Trial in Beijing (SBRT plus tislelizumab and regorafenib)
Recruiting
- Unresectable Hepatocellular Carcinoma
- Oligometastatic Disease
- SBRT plus tislelizumab and regorafenib
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Jun 15, 2023
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving
Recruiting
- Non-small Cell Lung Cancer
- Oligometastatic Disease
- ctDNA testing and whole exome sequencing
-
Guangzhou, Guangdong, ChinaGuangdong Lung Cancer Institute, Guangdong Provincial People's H
Dec 5, 2022
Non Small Cell Lung Cancer Trial in Sweden (Standard systemic therapy + radiotherapy, Standard systemic therapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Standard systemic therapy + radiotherapy
- Standard systemic therapy
-
Gothenburg, Sweden
- +5 more
Nov 17, 2023
Oligometastatic Prostate Carcinoma Trial in China (ADT combined with abiraterone, neoadjuvant hormone and RT)
Not yet recruiting
- Oligometastatic Prostate Carcinoma
- ADT combined with abiraterone
- neoadjuvant hormone and RT
-
Hefei, Anhui, China
- +5 more
Jan 28, 2023
Oligometastatic Prostate Cancer (OMPC) Trial (AAA617)
Not yet recruiting
- Oligometastatic Prostate Cancer (OMPC)
- (no location specified)
Jul 3, 2023
Colorectal Cancer, Oligometastatic Disease Trial in Australia (Local Ablative Therapy, Standard first-line systemic treatment)
Recruiting
- Colorectal Cancer
- Oligometastatic Disease
- Local Ablative Therapy
- Standard first-line systemic treatment
-
Albury, New South Wales, Australia
- +8 more
May 15, 2023
SBRT for Oligometastatic Castration-Refractory Prostate Cancer
Completed
- Prostate Cancer
- SBRT
-
Rochester, MinnesotaMayo Clinic
Aug 23, 2022
Oligometastatic Gastric Adenocarcinoma Trial in Verona (FOLFOX and PIPAC)
Recruiting
- Oligometastatic Gastric Adenocarcinoma
- FOLFOX and PIPAC
-
Verona, ItalyAOUI Verona
Jul 19, 2022
Spinal Metastases, Spinal Tumor, Radiotherapy Trial in Shanghai (total en bloc spondylectomy)
Recruiting
- Spinal Metastases
- +4 more
- total en bloc spondylectomy
-
Shanghai, Shanghai, ChinaShanghai Changzheng hospital
Nov 9, 2023
Breast Cancer Trial in São Paulo (radiation, procedure, other)
Recruiting
- Breast Cancer
- Radiotherapy
- +2 more
-
São Paulo, SP, BrazilICESP
Aug 5, 2022
Pancreatic Ductal Adenocarcinoma Trial (Thermal Ablation, Chemotherapy)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- Thermal Ablation
- Chemotherapy
- (no location specified)
Nov 9, 2022
Breast Cancer Stage IV, Oligometastatic Disease Trial (SABR)
Recruiting
- Breast Cancer Stage IV
- Oligometastatic Disease
- SABR
-
Gothenburg, Västra Götalandsregionen, SwedenSahlgrenska University Hospital
Oct 18, 2022
Prostate Cancer Trial ([177Lu]Lu-PSMA I&T, Stereotactic Radiotherapy)
Not yet recruiting
- Prostate Cancer
- [177Lu]Lu-PSMA I&T
- Stereotactic Radiotherapy
- (no location specified)
May 30, 2023
NSCLC Trial in Ostrava (primary tumour radiotherapy, stereotactic body radiotherapy, maintenance radiotherapy)
Recruiting
- Non-small Cell Lung Cancer
- primary tumour radiotherapy
- +2 more
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Dec 6, 2022
Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester
Active, not recruiting
- Metastatic Prostate Adenocarcinoma
- +6 more
- Intensity-Modulated Radiation Therapy
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023